Related Experiment Videos
Is renal dose dopamine protective or therapeutic? No
1Department of Anaesthesia and Intensive Care, Faculty of Medicine and Health Sciences, University of Newcastle, Callaghan, Australia.
Critical Care Clinics
|July 1, 1996
Summary
Low-dose dopamine does not prevent or improve acute kidney injury in critically ill patients. Its use may be limited to a diuretic effect in specific ventilated patients unresponsive to standard treatments.
Area of Science:
- Nephrology
- Critical Care Medicine
- Pharmacology
Background:
- Acute kidney injury (AKI) is a common complication in critically ill patients.
- The role of low-dose dopamine in managing AKI remains controversial.
- Understanding dopamine's effects is crucial for optimizing patient care.
Purpose of the Study:
- To evaluate the efficacy of low-dose dopamine in preventing or treating AKI in critically ill patients.
- To review the pharmacological effects and adverse events associated with low-dose dopamine.
- To define a potential evidence-based role for low-dose dopamine in specific patient populations.
Main Methods:
- Literature review and evidence synthesis.
- Analysis of pharmacological properties of dopamine (inotropic and diuretic effects).
- Assessment of adverse effects reported in clinical studies.
Main Results:
- Low-dose dopamine has not demonstrated efficacy in averting AKI onset or improving its course.
- Dopamine exhibits inotropic and diuretic properties.
- Adverse effects of dopamine require careful consideration.
Conclusions:
- Low-dose dopamine is not recommended for preventing or treating AKI in the general critically ill population.
- A potential, limited role exists for dopamine as a diuretic in ventilated, euvolemic patients refractory to conventional diuretics.
- Further research may clarify specific indications and risks.